6MFT image
Entry Detail
PDB ID:
6MFT
Title:
Crystal structure of glycosylated 426c HIV-1 gp120 core G459C in complex with glVRC01 A60C heavy chain
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2018-09-12
Release Date:
2018-11-14
Method Details:
Experimental Method:
Resolution:
2.32 Å
R-Value Free:
0.29
R-Value Work:
0.24
R-Value Observed:
0.24
Space Group:
C 1 2 1
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:Gp120
Mutations:G459C
Chain IDs:E (auth: G), F (auth: C)
Chain Length:347
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Heavy Chain glVRC01
Chain IDs:A (auth: H), C (auth: A)
Chain Length:233
Number of Molecules:2
Biological Source:Homo sapiens
Polymer Type:polypeptide(L)
Description:Light chain glVRC01
Chain IDs:B (auth: L), D (auth: B)
Chain Length:210
Number of Molecules:2
Biological Source:Homo sapiens
Primary Citation
Germline VRC01 antibody recognition of a modified clade C HIV-1 envelope trimer and a glycosylated HIV-1 gp120 core.
Elife 7 ? ? (2018)
PMID: 30403372 DOI: 10.7554/eLife.37688

Abstact

VRC01 broadly neutralizing antibodies (bnAbs) target the CD4-binding site (CD4BS) of the human immunodeficiency virus-1 (HIV-1) envelope glycoprotein (Env). Unlike mature antibodies, corresponding VRC01 germline precursors poorly bind to Env. Immunogen design has mostly relied on glycan removal from trimeric Env constructs and has had limited success in eliciting mature VRC01 bnAbs. To better understand elicitation of such bnAbs, we characterized the inferred germline precursor of VRC01 in complex with a modified trimeric 426c Env by cryo-electron microscopy and a 426c gp120 core by X-ray crystallography, biolayer interferometry, immunoprecipitation, and glycoproteomics. Our results show VRC01 germline antibodies interacted with a wild-type 426c core lacking variable loops 1-3 in the presence and absence of a glycan at position Asn276, with the latter form binding with higher affinity than the former. Interactions in the presence of an Asn276 oligosaccharide could be enhanced upon carbohydrate shortening, which should be considered for immunogen design.

Legend

Protein

Chemical

Disease

Primary Citation of related structures